Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
23,944,922
-
Total 13F shares
-
836,863
-
Share change
-
+812,246
-
Total reported value
-
$4,377,386
-
Put/Call ratio
-
6.5%
-
Price per share
-
$5.23
-
Number of holders
-
32
-
Value change
-
+$4,248,641
-
Number of buys
-
27
Institutional Holders of Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) as of Q1 2024
As of 31 Mar 2024,
Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
836,863 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Cresset Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, STATE STREET CORP, HB Wealth Management, LLC, Royal Bank of Canada, and IPG Investment Advisors LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.